A phase 2 study with tafasitamab and zanubrutinib in newly diagnosed chronic lymphocytic leukemia/small lymphocytic lymphoma – taza CLL
Year: 2025
Type: conference-abstract
Source: Blood
Authors: Georgios Pongas, Matthew Mei, Lu Chen, Geoffrey Shouse, Rachel Bellsmith, Ivana Melgar, Steven Rosen, Tanya Siddiqi, Alexey Danilov
Institutions: University of Miami, City Of Hope National Medical Center
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7108675532
Cites:
Cited by:
Related to: